Novozymes A/S (CPH:NSIS.B)
399.50
-0.90 (-0.22%)
At close: Nov 26, 2025
Novozymes Revenue
Novozymes had revenue of 1.06B EUR in the quarter ending September 30, 2025, with 8.86% growth. This brings the company's revenue in the last twelve months to 4.14B, up 19.33% year-over-year. In the year 2024, Novozymes had annual revenue of 3.83B with 59.58% growth.
Revenue (ttm)
4.14B EUR
Revenue Growth
+19.33%
P/S Ratio
6.01
Revenue / Employee
391.46K EUR
Employees
10,582
Market Cap
186.01B DKK
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.83B | 1.43B | 59.58% |
| Dec 31, 2023 | 2.40B | 42.38M | 1.80% |
| Dec 31, 2022 | 2.36B | 348.99M | 17.36% |
| Dec 31, 2021 | 2.01B | 128.32M | 6.82% |
| Dec 31, 2020 | 1.88B | -41.10M | -2.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SP Group | 2.85B |
| H+H International | 2.78B |
| Flügger group | 2.27B |
| RIAS A/S | 320.36M |
| Hove A/S | 204.35M |
| Scandinavian Investment Group | 25.10M |
Novozymes News
- 20 days ago - Novozymes A/S (NVZMY) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Novonesis A/S (NVZMF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Novonesis: Industry Leader With Defensive Characteristics And Solid Growth - Seeking Alpha
- 7 months ago - Novonesis A/S (NVZMF) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 9 months ago - Novonesis A/S (NVZMF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Top 3 global stocks poised for 40% gains by 2025 - Invezz
- 1 year ago - Novonesis A/S (NVZMF) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Novonesis: Underperformance In Price, But Now I'm Buying (Rating Upgrade) - Seeking Alpha